Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Bacteriology

Bacillus thuringiensis subsp.konkukian (Serotype H34) Superinfection: Case Report and Experimental Evidence of Pathogenicity in Immunosuppressed Mice

Eric Hernandez, Francoise Ramisse, Jean-Pierre Ducoureau, Thierry Cruel, Jean-Didier Cavallo
Eric Hernandez
Laboratoire de Biologie and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francoise Ramisse
Centre d’Etude du Bouchet BP3, 91710 Vert-le-Petit,France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Pierre Ducoureau
Service de Réanimation, Hôpital des Armées Begin, 94160 Saint Mandé, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thierry Cruel
Laboratoire de Biologie and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Didier Cavallo
Service de Réanimation, Hôpital des Armées Begin, 94160 Saint Mandé, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.36.7.2138-2139.1998
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

We present a case of severe war wounds infected by Bacillus thuringiensis serotype H34 and describe the experimental protocol used to demonstrate its ability to infect mice after cutaneous inoculation. This case is interesting because B. thuringiensis is considered to be a contaminant in laboratories and receives inadequate attention.

Bacillus species are widely distributed in nature, and finding a Bacillus sp. in medical practice, aside from B. anthracis and B. cereus, is often considered clinically irrelevant. B. thuringiensis is closely related to B. cereus and is used extensively around the world as a pesticide in forestry and agriculture (1). The two species can be differentiated only by the production of the plasmid-encoded delta endotoxin, which is pathogenic for larvae of Lepidoptera. As this characteristic is not consistent, many consider B. thuringiensis to be a variant of B. cereus.

Infection in humans is unusual and, except for reports on infection of the gastrointestinal tract or laboratory contamination, there is only one clinical report of infection by this microorganism (2). We describe a case of severe war wounds infected by B. thuringiensis serotype H34 (4) and present experimental evidence for the pathogenicity of this strain in a mouse model of cutaneous infection.

Case report.The patient was a healthy 28-year-old French soldier severely wounded in March of 1995 by a land mine explosion in former Yugoslavia. When he was admitted to the emergency room of the French military hospital in Sarajevo, Yugoslavia, the patient presented with hemorrhagic shock, a pulmonary blast, shrapnel lesions in the left leg, and multiple fractures in the left knee. Immediate antibioprophylaxis, given on the battlefield, included penicillin G (5 × 106 U/24 h) associated with metronidazole (1.5 g/24 h). After immediate surgery, the patient was evacuated within 24 h to the Begin Army Hospital (Paris, France). Upon admission, he was found to have an oral temperature of 38.7°C, a pulse of 100 beats/min, blood pressure of 130/90 mm Hg, and a respiratory rate of 24 breaths/min. His leukocyte count was 10,200 cells/mm3. He was immunocompetent and a nonsmoker and had no history of illness.

Physical examination revealed abscesses on the left thigh and knee, and biopsy specimens of the wounds were obtained surgically. Microscopic examination showed large gram-positive rods with endospores. After routine culture, the colonies on blood agar medium were shown to be large (5 mm), beta-hemolytic, flat, white, and rough. Catalase was positive, and oxidase was negative. The bacterium was mobile. Biochemical tests performed with API 50-CHB and 20-E (Biomerieux, S. A., Lyon, France) identified the strain as B. cereus, disagreeing with the results obtained by the Vitek system (Biomerieux Vitek, St. Louis, Mo.), which identified the strain asB. thuringiensis. The results of the biochemical reactions are presented in Table 1.

View this table:
  • View inline
  • View popup
Table 1.

Biochemical reactions of B. thuringiensisserotype H34 isolated from war wounds

As this finding was unusual, the strain was sent to M. Lecadet and her colleagues at the World Health Organization collaborating center for entomopathogens (Unité des Bactéries Entomopathogènes, Institut Pasteur, Paris, France), who identified the strain as B. thuringiensis subsp.konkukian (serotype H34).

The presence of crystal in sporulated culture, which is characteristic of B. thuringiensis, was recorded by direct examination of a fresh preparation under a phase-contrast microscope or after specific coloration of proteins with Coomassie brilliant blue solution.

The standard characteristics according to the method described by Sneath (5) were determined mainly by the APIBacillus (API-20E and API-50CH) system.

H serotyping based on flagellar antigens was performed according to the agglutination method described by de Barjac (3) with specific antisera for the 79 known B. thuringiensisserovars. In brief, an early exponentially growing culture is inoculated on the agar surface of a small, special tube filled with soft nutrient agar. If mobile, the bacteria migrate in 24 h. The cells obtained by this method are then tested for agglutination with various antisera.

Antimicrobial susceptibility was tested by E test and disk diffusion. Interpretive criteria for Staphylococci were used because there are no National Committee for Clinical Laboratory Standards guidelines for interpreting the results of susceptibility tests onBacillus spp. Results (MICs in micrograms per milliliter and zone diameters in millimeters) showed resistance to penicillin G (MIC, 32; diameter, 8) and ampicillin (MIC, 16; diameter, 12) and a paradoxical susceptibility to piperacillin (MIC, 1; diameter, 27). The presence of β-lactamase was indicated by the Cefinase test (Biomerieux), performed in liquid medium. The strain was also susceptible to imipenem (MIC, 0.047; diameter, 34 mm), vancomycin (MIC, 2; diameter, 18), gentamicin (MIC, 0.5; diameter, 24) and ciprofloxacin (MIC, 0.25; diameter, 31).

The patient recovered after 15 days of intensive care, multiple surgical cleansings, and an antibiotic treatment of ciprofloxacin associated with gentamicin that was administered for 10 days.

The isolation of B. thuringiensis from wound abscesses raised the question of whether this bacterium was the causative agent of the infection or simply a contaminant, leading us to investigate the potential pathogenicity of this strain in mammals with a mouse model of cutaneous infection. After depilation of a 2-cm2 area of their skin, six groups of 5-week-old female BALB/c mice were infected by an application of a bacterial suspension containing, respectively, 105, 106, or 107 CFU per mouse. For each inoculum, 4 days before the experiment, one group of mice was immunosuppressed by intravenous injection of cyclophosphamide (200 mg/kg of body weight); a control group was not immunosuppressed. Cutaneous inflammatory lesions occurred in all animals when the 107 CFU inoculum was used. Lesions healed spontaneously after 48 h in nonimmunosuppressed mice but increased in the other group. Two days after the infection, the mice were sacrificed, and the inner side of the skin (4 cm2) was aseptically removed and grown on a blood agar medium. B. thuringiensis was recovered only in the samples from the immunosuppressed mice. The bacterial count was correlated with the quantity of the cutaneous bacterial inoculum. Bacteriological examination of tissue stained by Gram stain and periodic acid-Schiff stain revealed that B. thuringiensiswas associated with tissue necrosis and polymorphonuclear infiltrates (Fig. 1).

Fig. 1.
  • Open in new tab
  • Download powerpoint
Fig. 1.

Gram stain of tissue revealing association of B. thuringiensis with tissue necrosis and polymorphonuclear infiltrates. Abbreviations: b, bacteria; f, fat; m, muscle; n, deep necrosis. Magnification, ×400.

The animal model used demonstrates the ability of B. thuringiensis subsp. konkukian (serotype H34) to produce infection and myonecrosis in the absence of an effective immune response. Likewise, the clinical data suggest that disease may also be produced in patients with tissue devitalization caused by massive tissue destruction. Like B. cereus, this bacterium forms spores which are normally found in the soil. Presumably, soil and dust particles projected by the land mine explosion were the source of the organism in this unusual case of infection. This reported episode of soft-tissue infection and necrosis by B. thuringiensis is reminiscent of B. cereus infection after severe trauma (6).

ACKNOWLEDGMENTS

We thank Alan Tallmon, minister of the French Reformed Church, for his help in the preparation of the manuscript. We also thank Marguerite Lecadet (Unité des Bactéries Entomopathogènes, Institut Pasteur, Paris, France) for her valuable help in identifyingB. thuringiensis subsp. konkukian.

FOOTNOTES

    • Received 15 January 1998.
    • Returned for modification 29 January 1998.
    • Accepted 13 April 1998.
  • Copyright © 1998 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Aronson A. I.,
    2. Beckman W.,
    3. Dunn P.
    Bacillus thuringiensis and related insect pathogens.Microbiol. Rev.501986124
    OpenUrlFREE Full Text
  2. 2.↵
    1. Damgaard P. H.,
    2. Granum P. E.,
    3. Bresciani J.,
    4. Torregrossa M. V.,
    5. Eilenberg J.,
    6. Valentino L.
    Characterization of Bacillus thuringiensis isolated from infections in burn wounds.FEMS Immunol. Med. Microbiol.1819974753
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. de Barjac H.
    Identification of H-serotypes of Bacillus thuringiensis Microbial control of pests and plant diseases. Burges H. D. 1981 35 43 The Academic Press Co. London, England
  4. 4.↵
    1. Lee H. H.,
    2. Lee J. A.,
    3. Lee K. Y.,
    4. Chung J. D.,
    5. De Barjac H.,
    6. Charles J. F.,
    7. Cosmao-Dumanoir V.,
    8. Frachon E.
    New serovars of Bacillus thuringiensis: Bacillus thuringiensis ser. coreanensis (serotype H25), Bacillus thuringiensis ser. leesis (serotype H33) and Bacillus thuringiensis ser. konkukian (ser. H34).J. Invertebr. Pathol.631994217219
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Sneath P. H. A.
    Endospore-forming Gram-positive rods and cocci Bergey’s manual of systematic bacteriology 1st ed. Butler J. P. 1986 1104 1140 Williams & Wilkins Baltimore, Md
  6. 6.↵
    1. Wong M.,
    2. Dolan M. J.
    Significant infections due to Bacillus species following abrasions associated with motor vehicle related trauma.Clin. Infect. Dis.151992855857
    OpenUrlCrossRefPubMed
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Bacillus thuringiensis subsp.konkukian (Serotype H34) Superinfection: Case Report and Experimental Evidence of Pathogenicity in Immunosuppressed Mice
Eric Hernandez, Francoise Ramisse, Jean-Pierre Ducoureau, Thierry Cruel, Jean-Didier Cavallo
Journal of Clinical Microbiology Jul 1998, 36 (7) 2138-2139; DOI: 10.1128/JCM.36.7.2138-2139.1998

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Bacillus thuringiensis subsp.konkukian (Serotype H34) Superinfection: Case Report and Experimental Evidence of Pathogenicity in Immunosuppressed Mice
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Bacillus thuringiensis subsp.konkukian (Serotype H34) Superinfection: Case Report and Experimental Evidence of Pathogenicity in Immunosuppressed Mice
Eric Hernandez, Francoise Ramisse, Jean-Pierre Ducoureau, Thierry Cruel, Jean-Didier Cavallo
Journal of Clinical Microbiology Jul 1998, 36 (7) 2138-2139; DOI: 10.1128/JCM.36.7.2138-2139.1998
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Bacillaceae Infections
Bacillus thuringiensis
Skin Diseases, Bacterial
superinfection
Wound Infection

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X